Kaleido Biosciences Analysis
Kaleido Biosciences is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of Kaleido Biosciences pink sheet analysis is to determine its intrinsic value, which is an estimate of what Kaleido Biosciences is worth, separate from its market price. There are two main types of Kaleido Biosciences' stock analysis: fundamental analysis and technical analysis.
The Kaleido Biosciences pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Kaleido |
Kaleido Pink Sheet Analysis Notes
The company has price-to-book ratio of 0.0. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kaleido Biosciences recorded a loss per share of 2.16. The entity had not issued any dividends in recent years. Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 76 people.The quote for Kaleido Biosciences is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Kaleido Biosciences contact the company at 617 674 9000 or learn more at https://kaleido.com.Kaleido Biosciences Investment Alerts
| Kaleido Biosciences is not yet fully synchronised with the market data | |
| Kaleido Biosciences has some characteristics of a very speculative penny stock | |
| Kaleido Biosciences has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.1 M. Net Loss for the year was (90.29 M) with loss before overhead, payroll, taxes, and interest of (66.7 M). | |
| Kaleido Biosciences currently holds about 38.47 M in cash with (77.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.9. |
Kaleido Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 421.96 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Kaleido Biosciences's market, we take the total number of its shares issued and multiply it by Kaleido Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Kaleido Biosciences Outstanding Bonds
Kaleido Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Kaleido Biosciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Kaleido bonds can be classified according to their maturity, which is the date when Kaleido Biosciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Kaleido Biosciences to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Kaleido Pink Sheet
If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |